Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate Thalidomide for treatment of disseminated MALT
Lymphoma or at relapse following helicobacter pylori (HP) - eradication or chemotherapy or
radiation.